Form 4 for INSP Inspire Medical Systems, Inc.
Accepted 2023-02-21 00:00:00 ET · period of report 2023-02-16 · accession 0001104659-23-023901 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-21 | 2023-02-16 | INSP | Ebeling Philip | COO | S - Sale+OE | $275.00 | -7,000 | 243 | -97% | -$1.93M |
| D | 2023-02-21 | 2023-02-16 | INSP | Ebeling Philip | COO | M - OptEx | $194.82 | +7,000 | 7,243 | +2,881% | +$1.36M |
| D | 2023-02-21 | 2023-02-16 | INSP | Ebeling Philip | COO | M - OptEx | $0.00 | -7,000 | 10.3K | -40% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-16 | S | D | 7,000 | $275.00 | 243 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-16 | M | A | 7,000 | $194.82 | 7,243 | D | — | — | |
| 3 | Derivative | Employee Stock Option (Right to Buy) | 2023-02-16 | M | D | 7,000 | $0.00 | 10,300 | D | $194.82 · — to 2030-12-14 | 7,000 Common Stock | (F1) The option has vested and became exercisable as to 25% of the underlying shares on the first anniversary of December 14, 2020 and the remaining 75% of the underlying shares have vested or will vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. |